Product Image

Once-Daily Health Booster

4.5
★ ★ ★ ★ ★
(1031 ratings)
Chlorophyllin 100 mg
Vitamin K 3735 mcg
Product Image
Score61
Broad antioxidant ingredients and easy dosing are offset by proprietary-blend opacity and an unusually high vitamin K amount.
How scoring works
Softgel
Quantity:60 Softgel(s) • (60 servings)
Goals:
Heart Health
Anti-Aging
General Health
Detoxification

Score 61

Broad antioxidant ingredients and easy dosing are offset by proprietary-blend opacity and an unusually high vitamin K amount.
How scoring works
$43.50($0.72 per serving)
Vitacost
$ 43.53
iHerb
$ 45.00
Pure Formulas
$ 43.50
Report prices

Analysis

The formula combines natural vitamin E and mixed tocotrienols with chlorophyllin, saffron, lycopene, and a carotenoid blend. That mix covers several antioxidant pathways and offers more breadth than a basic vitamin E product.

The 173 mg MacuGuard blend does not disclose each component's amount, so its practical strength cannot be fully assessed. Vitamin K reaches 3,735 mcg, far above ordinary nutritional maintenance, and deserves deliberate coordination with total intake.

A once-daily softgel makes use convenient, though the serving value is only moderate. It best fits users specifically seeking this antioxidant combination who do not use vitamin-K-antagonist medication.

Who is it for
  • Adults seeking broad carotenoid and antioxidant support
  • Users wanting chlorophyllin with vitamin E compounds
  • People not taking vitamin-K-antagonist medication
Best for
  • Broad antioxidant coverage
  • Carotenoid support
  • Once-daily convenience

Pros

  • Uses natural vitamin E
  • Includes mixed tocotrienols
  • Provides 100 mg chlorophyllin
  • Contains saffron and lycopene

Cons

  • MacuGuard blend amounts are not disclosed
  • Vitamin K dose is unusually high
  • Serving value is only moderate
  • The formula covers many aims without a clearly defined primary use

Warnings

  • The 3,735 mcg vitamin K amount can interfere with warfarin and other vitamin-K-antagonist medicines
  • People using vitamin-K antagonists need medically coordinated and consistent vitamin K intake
  • The proprietary blend prevents checking individual carotenoid doses

Nutrient quality

63 Moderate impact

Natural vitamin E and sodium magnesium chlorophyllin are favorable, but the vitamin K form and blend composition are unclear. Several ingredients have useful amounts, though the hidden blend contents prevent a complete dose assessment.

.

Ingredient transparency

56 Moderate impact

Named actives have stated totals, but individual ingredients inside proprietary blends lack amounts. The supplied label data does not include a complete inactive ingredient list.

.

Customer satisfaction

70 High impact

The aggregate satisfaction measure and review volume support a favorable first impression. Missing firsthand feedback leaves repeat complaints and real-world purpose fit uncertain.

.

Value for money

59 Moderate impact

The formula offers broad ingredient coverage, but major disclosure gaps temper its quality-adjusted value. Each serving has moderate value given the useful actives and unresolved blend composition.

.
Report analysis

Goals

Heart Health
Impact
High effect
B- Goal FitC+ Strength of SupportC+ CoverageC Formula Quality
Vitamin K · 3735 mcg

Vitamin K and vitamin E provide calcium-management and antioxidant support relevant to vascular health. The broader antioxidant blend may add support, but the product is a general health booster rather than a focused heart formula.

The vitamin K amount is substantial, yet its forms are not separated and two proprietary blends obscure individual contributions. Vitamin K can oppose warfarin and other vitamin K antagonist medicines, making this high-dose formula unsuitable without coordinated anticoagulation management.

Study evidence
Vitamin K Mixed 62 studies
Anti-Aging
Impact
Moderate effect
C Goal FitC- Strength of SupportC- CoverageC- Formula Quality
Vitamin K · 3735 mcg

Vitamin E forms, lycopene, saffron, and macular antioxidants provide broad oxidative and structural support for healthy aging. The formula is antioxidant heavy and does not directly address mitochondrial decline, glycation, or muscle preservation.

Some actives are clearly dosed, but two proprietary blends hide key internal amounts and the vitamin K form is absent. The very high vitamin K amount can counteract warfarin, while vitamin E may increase bleeding tendency with anticoagulant or antiplatelet medicines.

Study evidence
Vitamin E Supportive 19 studies
Vitamin K Supportive 27 studies
General Health
Impact
Moderate effect
C+ Goal FitD- Strength of SupportB- CoverageD+ Formula Quality
Vitamin K · 3735 mcg

Vitamin E, tocotrienols, vitamin K, carotenoid-related blends, saffron, and chlorophyllin span several antioxidant and tissue-support pathways. The softgel also suits delivery of fat-soluble compounds.

Key weaknesses are the undisclosed vitamin K subtype and multiple proprietary blends that obscure active composition. The very large total vitamin K amount may oppose warfarin, and the mixed formula lacks the clarity needed for confident routine use.

Study evidence
Vitamin K Supportive 34 studies
Detoxification
Impact
Moderate effect
D Goal FitB+ Strength of SupportD- CoverageD- Formula Quality
Vitamin E · 55 mg

Sodium magnesium chlorophyllin provides a strong gut-level binding amount for certain ingested compounds. Its action is situational and does not directly support liver conjugation or antioxidant recycling.

The broader antioxidant and eye-health blend adds little metabolic-clearance depth and includes proprietary ingredients. The very high vitamin K content may interfere with warfarin and other vitamin K antagonist medicines.

Study evidence
Chlorophyllin Supportive 3 studies

Ingredients

IngredientAmount per serving
Vitamin E (D-Alpha-Tocopherol)
30.2 mg
Vitamin K
3735 mcg
MacuGuard Proprietary Blend
173 mg
Chlorophyllin (Sodium Magnesium Chlorophyllin)
100 mg
Mixed Tocotrienols
55 mg
Saffron extract
20 mg
Lycopene Proprietary Blend (Lyc-O-Mato natural Tomato extract, micronized Lycopene)
10 mg
Adults 18–50
Report overview
B+ Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyD+ Value

Provides the preferred sodium magnesium chlorophyllin form at a high-potency amount in one softgel. The botanical source and elemental magnesium contribution are not stated, and the broader formula carries a higher chlorophyllin-specific cost. Its very high vitamin K content may interfere with warfarin and other vitamin K antagonist therapy.

Vitamin K · 3735 mcg OverallScore10
F Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyF Value

The softgel format is favorable for a fat-soluble vitamin, but the very large vitamin K amount has no disclosed form or subtype. Without a stated MK-7 dose, neither suitability nor dose quality can be established for targeted K2 use. Anyone using warfarin should note that such a large vitamin K amount may oppose the medicine's anticoagulant effect.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Low dietary vitamin E intake is associated with high risk of incident dementia among older adults: The Shanghai Aging Study.
    Liu S; Luo J; Xiao Z; Wu W; Liang X; Ding S; Zhao Q; Zhao X; Wang Y; Ding D · Frontiers in nutrition · 2024
    Cohort study1,550 participantsAnti-Aging forVitamin E
  2. Nutrients and bioactives in green leafy vegetables and cognitive decline: Prospective study.
    Morris MC; Wang Y; Barnes LL; Bennett DA; Dawson-Hughes B; Booth SL · Neurology · 2019
    Cohort study960 participantsAnti-Aging forVitamin E
  3. Low Intake of Vitamin E Accelerates Cellular Aging in Patients With Established Cardiovascular Disease: The CORDIOPREV Study.
    Corina A; Rangel-Zúñiga OA; Jiménez-Lucena R; Alcalá-Díaz JF; Quintana-Navarro G; Yubero-Serrano EM; López-Moreno J; Delgado-Lista J; Tinahones F; Ordovás JM; López-Miranda J; Pérez-Martínez P · The journals of gerontology. Series A, Biological sciences and medical sciences · 2020
    Observational study1,002 participantsAnti-Aging forVitamin E
  4. The L-shaped link between total antioxidant capacity and phenotypic age acceleration: evidence from NHANES 2003-2010.
    Wu Y; Xiang M; Zhao Y; Zhang Y; Cheng W; Deng J · Biogerontology · 2025
    Cross-sectional study16,395 participantsAnti-Aging forVitamin E
  5. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M · Experimental gerontology · 2014
    Cohort study140 participantsAnti-Aging forVitamin E
  6. Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts.
    Shea MK; Barger K; Booth SL; Matuszek G; Cushman M; Benjamin EJ; Kritchevsky SB; Weiner DE · The American journal of clinical nutrition · 2020
    Meta-analysis3,891 participants3 studies pooledAnti-Aging General Health forVitamin K
  7. Topical Menaquinone‑7 (Vitamin K2, MK-7) as a Mitochondrial Bioenergetic Activator for Skin Anti-Aging: Mechanistic Evidence in Skin Cells and a Randomized Split-Face/Neck Study.
    Huang H; Wei R; Xu C; Liu C; Zhao S; Li Y; Wang M · ACS omega · 2026
    Randomized trial30 participantsAnti-Aging forVitamin K
  8. Vitamin K status and cognitive function in healthy older adults.
    Presse N; Belleville S; Gaudreau P; Greenwood CE; Kergoat MJ; Morais JA; Payette H; Shatenstein B; Ferland G · Neurobiology of aging · 2014
    Cross-sectional study320 participantsAnti-Aging forVitamin K
  9. High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam.
    Machado-Fragua MD; Hoogendijk EO; Struijk EA; Rodriguez-Artalejo F; Lopez-Garcia E; Beulens JW; van Ballegooijen AJ · European journal of nutrition · 2021
    Cohort study644 participantsAnti-Aging forVitamin K
  10. Vitamin K Concentration and Cognitive Status in Elderly Patients on Anticoagulant Therapy: A Pilot Study.
    Alisi L; Cafolla C; Gentili A; Tartaglione S; Curini R; Cafolla A · Journal of aging research · 2022
    Cross-sectional study85 participantsAnti-Aging forVitamin K
  11. Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1).
    Gross-Steinmeyer K; Eaton DL · Toxicology · 2012
    Narrative reviewDetoxification forChlorophyllin
  12. Aflatoxin and Liver Cancer in China: The Evolving Research Landscape.
    Chen JG; Kensler TW; Sun GJ; Zhu J; Lu JH; Pan D; Zhang YH; Groopman JD · Toxins · 2026
    Narrative reviewDetoxification forChlorophyllin
  13. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer
    P A Egner, J B Wang, Y R Zhu, B C Zhang, Y Wu, Q N Zhang, G S Qian, S Y Kuang, S J Gange, L P Jacobson, K J Helzlsouer, G S Bailey, J D Groopman, T W Kensler · Proceedings of the National Academy of Sciences of the United States of America · 2001
    Randomized trial169 participantsDetoxification forChlorophyllin
  14. Dietary vitamin K intake associates with reduced all-cause mortality in non-alcoholic fatty liver disease patients.
    Huang Y; Zhu X; Han L; Hu H · Scientific reports · 2025
    Cohort study7,857 participantsGeneral Health forVitamin K
  15. The Effect of Topical Vitamin K1 on the Treatment of Cetuximab-Induced Skin Rashes in Metastatic Colorectal Cancer Patients.
    Roayaei M; Rezaei M; Najafizade N · Advanced biomedical research · 2024
    Randomized trial49 participantsGeneral Health forVitamin K
  16. Effect of vitamin K on improving post‑kidney transplant outcomes: a meta‑analysis.
    Sun Z; Zhu K; Liang G; Yan F; Chao S; Jia L; Niu Y · Experimental and therapeutic medicine · 2023
    Meta-analysis7 studies pooledGeneral Health forVitamin K
  17. Vitamin K1 intake is associated with lower risk for all-cause and cardiovascular disease mortality in community-dwelling older Australian women.
    Dupuy M; Radavelli-Bagatini S; Zhong L; Dalla Via J; Zhu K; Blekkenhorst LC; Bondonno NP; Linneberg A; Bellinge JW; Schultz C; Courtney W; Prince RL; Hodgson JM; Lewis JR; Sim M · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2024
    Cohort study1,436 participantsGeneral Health forVitamin K
  18. Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
    Bellinge JW; Dalgaard F; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Sim M; Croft KD; Gislason G; Torp-Pedersen C; Tjønneland A; Overvad K; Hodgson JM; Schultz C; Bondonno NP · Journal of the American Heart Association · 2021
    Cohort study53,372 participantsHeart Health forVitamin K
  19. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
    Knapen MH; Braam LA; Drummen NE; Bekers O; Hoeks AP; Vermeer C · Thrombosis and haemostasis · 2016
    Randomized trial244 participantsHeart Health forVitamin K
  20. The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
    Bellinge JW; Francis RJ; Lee SC; Bondonno NP; Sim M; Lewis JR; Watts GF; Schultz CJ · The American journal of clinical nutrition · 2022
    Randomized trial149 participantsHeart Health forVitamin K
  21. Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
    Schultz CJ; Dalgaard F; Bellinge JW; Murray K; Sim M; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Gislason GH; Tjønneland A; Overvad K; Hodgson JM; Bondonno NP · Arteriosclerosis, thrombosis, and vascular biology · 2024
    Cohort study55,545 participantsHeart Health forVitamin K
  22. Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.
    Palmer CR; Bellinge JW; Dalgaard F; Sim M; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Croft KD; Gislason G; Tjønneland A; Overvad K; Schultz C; Lewis JR; Hodgson JM; Bondonno NP · European journal of epidemiology · 2021
    Cohort study56,048 participantsHeart Health forVitamin K